Liaoning Cheng Da Co Ltd
SSE:600739
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.27
12.74
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Liaoning Cheng Da Co Ltd
Cost of Revenue
Liaoning Cheng Da Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Liaoning Cheng Da Co Ltd
SSE:600739
|
Cost of Revenue
-¥9.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-1%
|
|
|
X
|
Xinhua Winshare Publishing and Media Co Ltd
SSE:601811
|
Cost of Revenue
-¥7.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
A
|
Anhui Xinhua Media Co Ltd
SSE:601801
|
Cost of Revenue
-¥8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-7%
|
|
|
S
|
Sinomach Automobile Co Ltd
SSE:600335
|
Cost of Revenue
-¥37.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Zhejiang Orient Financial Holdings Group Co Ltd
SSE:600120
|
Cost of Revenue
-¥437.3m
|
CAGR 3-Years
71%
|
CAGR 5-Years
47%
|
CAGR 10-Years
27%
|
|
|
Wuchan Zhongda Group Co Ltd
SSE:600704
|
Cost of Revenue
-¥570.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-15%
|
|
Liaoning Cheng Da Co Ltd
Glance View
Liaoning Cheng Da Co., Ltd. engages in the commodities distribution, import and export trading as well as biological drug manufacturing. The company is headquartered in Dalian, Liaoning and currently employs 3,268 full-time employees. The firm operates through four segments. The Commodity Trading segment is engaged in the retailing and wholesales of pharmaceuticals, as well as the trading of oil, coal and steel, among others. The Biopharmaceutical Manufacturing segment is engaged in the research and development, production and marketing of vaccines for human and animals. The Energy Development segment is engaged in the exploitation, production and sales of oil. The Financial Services segment is engaged in long-term investment businesses and fund businesses. The firm operates its businesses in both domestic and overseas markets.
See Also
What is Liaoning Cheng Da Co Ltd's Cost of Revenue?
Cost of Revenue
-9.7B
CNY
Based on the financial report for Sep 30, 2024, Liaoning Cheng Da Co Ltd's Cost of Revenue amounts to -9.7B CNY.
What is Liaoning Cheng Da Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-1%
Over the last year, the Cost of Revenue growth was -14%. The average annual Cost of Revenue growth rates for Liaoning Cheng Da Co Ltd have been 15% over the past three years , 10% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
